(Q48265633)

English

The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.

scientific article published on 10 January 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/29322205

The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/29322205

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Dominik Bettinger

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Leo Krafft

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Michael Schultheiss

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Hannes Philipp Neeff

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Lars Maruschke

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Michaela Schulenburg

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sonja Adebahr

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Simon Kirste

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Ursula Nestle

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Robert Thimme

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Anca-Ligia Grosu

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Thomas Baptist Brunner

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

10 January 2018

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/29322205

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

194

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

403-413

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

https://scigraph.springernature.com/pub.10.1007/s00066-017-1256-0

0 references

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Hepatocellular carcinoma: clinical frontiers and perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Albumin-Bilirubin Score: Predicting Short-Term Outcomes Including Bile Leak and Post-hepatectomy Liver Failure Following Hepatic Resection

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Radiation-associated liver injury.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

An overview of hypofractionation and introduction to this issue of seminars in radiation oncology.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Simultaneous integrated protection : A new concept for high-precision radiation therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

A challenge to traditional radiation oncology.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Gene signatures in the management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00066-017-1256-0

21 January 2018

An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29322205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29322205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29322205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-017-1256-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29322205%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48265633&oldid=1477580630"